The American College of Medical Genetics and Genomics (ACMG) said today it will establish a program designed to develop new evidence-based guidelines in medical...
The collaboration will integrate Thermo Fisher’s Orbitrap gas chromatography mass spectrometry (GC-MS) instrumentation into Owlstone’s breath biopsy platform to conduct metabolomics studies for unique biomarkers.
The test stratifies patients based on their risk of subsequently experiencing a severe disease course, which is characterized by the requirement for multiple escalations in treatment due to frequently relapsing or chronically active disease.
Developers of pharmacogenetic tests cheered in August when United Healthcare (UHC) concluded in a policy statement effective October 1, that “the use of pharmacogenetic...
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Company blames revenue dip on this year’s change in Current Procedural Terminology (CPT) codes covering hereditary cancer testing for two genes.
The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
The pilot project will provide information for 147 genes that are well-established indicators of increased risk for certain diseases for which clinical treatment guidelines are established.
The research is the first to show that skin exposure to UVB light alters the gut microbiome, which could provide new insights into approaches to manage and improve intestinal health.
A study of the tongue microbiome reveals some types of bacteria can distinguish people with early pancreatic cancer from healthy individuals